Tag Archive for: Clinical

Lytix Biopharma announces completion of patient recruitment in the ATLAS-IT-05 trial

/in

Oslo, 29 August 2023. Lytix Biopharma – Lytix Biopharma AS (“Lytix”) (Euronext Growth Oslo: LYTIX), a clinical stage immuno-oncology company, announces that it has completed recruitment of 20 patients in the ATLAS-IT-05 trial – a trial evaluating LTX-315, Lytix’s lead drug candidate. Read more…..

Read more

STORM Therapeutics announces closing of USD $30M Series B financing

/in

Proceeds will advance STORM’s potential first-in-class clinical program targeting METTL3 for treatment of solid tumors and leukemias  Financing will further expand STORM’s novel discovery platform to create additional products targeting RNA modification 14 December 2022, Cambridge, UK: STORM Therapeutics Ltd. (STORM), the clinical biotechnology company discovering and developing novel small molecule therapies targeting RNA modifying […]

Read more